Aurigene Pharmaceutical Services, the CRDMO arm of India-based Dr. Reddy’s, has signed a non-binding Memorandum of Understanding (MoU) with Kainomyx, a US-based company...
15.06.2020
- Dr. Reddy's Laboratories has entered into a non-exclusive licensing agreement with Gilead Sciences. The agreement will grant Dr. Reddy’s the right to register, manufacture and sell...
03.04.2018
- On Apr. 2, 2018, Erez Israeli joined Indian pharmaceutical company Dr. Reddy’s as COO and global head of Generics & PSAI. Israeli, former president & CEO of Enzymotec, succeeded...
02.03.2016
- US law firm Zeldes Haeggquist & Eck has started investigating a possible violation of federal securities laws by Indian generics manufacturer Dr. Reddy’s Laboratories and US...
07.04.2015
- Belgium's UCB has agreed to sell its established brands in India, including its franchises in the areas of allergies and respiratory disorders, to Dr. Reddy's Laboratories for INR...
30.10.2012
- Dr. Reddy's Laboratories, India's No. 2 drugmaker by sales, reported a better-than-expected 32% rise in quarterly net profit as four new generic drugs drove sales in North America...
09.10.2012
- The Custom Pharmaceutical Services (CPS) business of Dr. Reddy's Laboratories today announced expansion in the areas of activated mPEG manufacturing and in the development and...
